Page results
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
This easy read page offers advice for patients on managing pain after an operation.
-
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
How UCLH uses clinical data in research.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
The Secretary of State for Health and Social Care Sajid Javid came to University College Hospital Grafton Way Building on Friday 4 February 2022.
-
Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer